News

The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...
The symptoms can include nerve pain, emotional numbness and sexual dysfunction and can last for years after stopping the ...